Patent Assignment
Reel/Frame 014709/0987
Assignment of Assignor's Interest
Recorded: 2003-11-20
Pages: 5
Assignor
PFIZER INC.
Executed: 2003-11-05
Assignee
NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
48 CHURCH STREET / SOFIA HOUSE, HAMILTON HM 12, BERMUDA
Covered Properties
(8)
Pyrrolidine Derivatives
Patent:
5,096,890 →
Application:
07/493,068 →
Pyrrolidine Derivatives
Patent:
5,233,053 →
Application:
07/800,191 →
Method of Enhancing Cognition
Patent:
5,837,724 →
Application:
08/872,891 →
Pharmaceutical Formulations Containing Darifenacin
Patent:
6,106,864 →
Application:
09/029,072 →
Pharmaceutical combinations
Application:
09/778,290 →
Publication:
US 2001/0044438
Method of Treating Irritable Bowel Syndrome
Method of treatment
Application:
10/256,420 →
Publication:
US 2003/0130338
Stable Hydrate of a Muscarinic Receptor Antagonist
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 27, 2010
From: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 025204/0049 →
Security Agreement
Mar 30, 2011
From: WARNER CHILCOTT COMPANY LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026064/0607 →
Release of Security Interest
Oct 31, 2013
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 031531/0538 →
Assignment of Assignor's Interest
Sep 29, 2016
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 040183/0129 →
Corrective Assignment to Correct the Us Patent No. 8,050,873 Previously Recorded on Reel 040183 Frame 0129. Assignor(S) Hereby Confirms the Assignment.
Feb 22, 2018
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 045417/0593 →